Ligand validation:6QLI

FNR: 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO-3,4-DIHYDRO-2H-BENZO[G]PTERIDIN-1-ID-10(5H)-YL)-5-O-PHOSPHONATO-D-RIBITOL

FNR is a Ligand Of Interest in 6QLI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QLI_FNR_A_302	88%	68%	0.091	0.967	0.59	0.65	-	-	0	0	100%	1
4ZAL_FNR_A_302	95%	7%	0.062	0.967	2.3	2.45	9	17	0	0	100%	1
3ZQU_FNR_A_1208	89%	23%	0.09	0.968	1.48	1.66	7	5	0	0	100%	1
4UTM_FNR_A_1362	100%	41%	0.037	0.994	1.4	0.92	5	2	1	0	100%	1
5LNJ_FNR_A_401	99%	49%	0.05	0.99	1.09	0.88	1	1	2	0	100%	0.95
5LGZ_FNR_A_403	99%	0%	0.049	0.986	6.3	3.19	19	16	1	0	100%	1
4RJE_FNR_C_401	99%	34%	0.048	0.983	1.4	1.2	3	5	2	0	100%	1
5CPL_FNR_A_402	99%	29%	0.053	0.986	1.83	1.02	8	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.